Cargando…
An entropic safety catch controls hepatitis C virus entry and antibody resistance
E1 and E2 (E1E2), the fusion proteins of Hepatitis C Virus (HCV), are unlike that of any other virus yet described, and the detailed molecular mechanisms of HCV entry/fusion remain unknown. Hypervariable region-1 (HVR-1) of E2 is a putative intrinsically disordered protein tail. Here, we demonstrate...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333995/ https://www.ncbi.nlm.nih.gov/pubmed/35796426 http://dx.doi.org/10.7554/eLife.71854 |
_version_ | 1784759002576453632 |
---|---|
author | Stejskal, Lenka Kalemera, Mphatso D Lewis, Charlotte B Palor, Machaela Walker, Lucas Daviter, Tina Lees, William D Moss, David S Kremyda-Vlachou, Myrto Kozlakidis, Zisis Gallo, Giulia Bailey, Dalan Rosenberg, William Illingworth, Christopher JR Shepherd, Adrian J Grove, Joe |
author_facet | Stejskal, Lenka Kalemera, Mphatso D Lewis, Charlotte B Palor, Machaela Walker, Lucas Daviter, Tina Lees, William D Moss, David S Kremyda-Vlachou, Myrto Kozlakidis, Zisis Gallo, Giulia Bailey, Dalan Rosenberg, William Illingworth, Christopher JR Shepherd, Adrian J Grove, Joe |
author_sort | Stejskal, Lenka |
collection | PubMed |
description | E1 and E2 (E1E2), the fusion proteins of Hepatitis C Virus (HCV), are unlike that of any other virus yet described, and the detailed molecular mechanisms of HCV entry/fusion remain unknown. Hypervariable region-1 (HVR-1) of E2 is a putative intrinsically disordered protein tail. Here, we demonstrate that HVR-1 has an autoinhibitory function that suppresses the activity of E1E2 on free virions; this is dependent on its conformational entropy. Thus, HVR-1 is akin to a safety catch that prevents premature triggering of E1E2 activity. Crucially, this mechanism is turned off by host receptor interactions at the cell surface to allow entry. Mutations that reduce conformational entropy in HVR-1, or genetic deletion of HVR-1, turn off the safety catch to generate hyper-reactive HCV that exhibits enhanced virus entry but is thermally unstable and acutely sensitive to neutralising antibodies. Therefore, the HVR-1 safety catch controls the efficiency of virus entry and maintains resistance to neutralising antibodies. This discovery provides an explanation for the ability of HCV to persist in the face of continual immune assault and represents a novel regulatory mechanism that is likely to be found in other viral fusion machinery. |
format | Online Article Text |
id | pubmed-9333995 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | eLife Sciences Publications, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-93339952022-07-29 An entropic safety catch controls hepatitis C virus entry and antibody resistance Stejskal, Lenka Kalemera, Mphatso D Lewis, Charlotte B Palor, Machaela Walker, Lucas Daviter, Tina Lees, William D Moss, David S Kremyda-Vlachou, Myrto Kozlakidis, Zisis Gallo, Giulia Bailey, Dalan Rosenberg, William Illingworth, Christopher JR Shepherd, Adrian J Grove, Joe eLife Microbiology and Infectious Disease E1 and E2 (E1E2), the fusion proteins of Hepatitis C Virus (HCV), are unlike that of any other virus yet described, and the detailed molecular mechanisms of HCV entry/fusion remain unknown. Hypervariable region-1 (HVR-1) of E2 is a putative intrinsically disordered protein tail. Here, we demonstrate that HVR-1 has an autoinhibitory function that suppresses the activity of E1E2 on free virions; this is dependent on its conformational entropy. Thus, HVR-1 is akin to a safety catch that prevents premature triggering of E1E2 activity. Crucially, this mechanism is turned off by host receptor interactions at the cell surface to allow entry. Mutations that reduce conformational entropy in HVR-1, or genetic deletion of HVR-1, turn off the safety catch to generate hyper-reactive HCV that exhibits enhanced virus entry but is thermally unstable and acutely sensitive to neutralising antibodies. Therefore, the HVR-1 safety catch controls the efficiency of virus entry and maintains resistance to neutralising antibodies. This discovery provides an explanation for the ability of HCV to persist in the face of continual immune assault and represents a novel regulatory mechanism that is likely to be found in other viral fusion machinery. eLife Sciences Publications, Ltd 2022-07-07 /pmc/articles/PMC9333995/ /pubmed/35796426 http://dx.doi.org/10.7554/eLife.71854 Text en © 2022, Stejskal, Kalemera et al https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Microbiology and Infectious Disease Stejskal, Lenka Kalemera, Mphatso D Lewis, Charlotte B Palor, Machaela Walker, Lucas Daviter, Tina Lees, William D Moss, David S Kremyda-Vlachou, Myrto Kozlakidis, Zisis Gallo, Giulia Bailey, Dalan Rosenberg, William Illingworth, Christopher JR Shepherd, Adrian J Grove, Joe An entropic safety catch controls hepatitis C virus entry and antibody resistance |
title | An entropic safety catch controls hepatitis C virus entry and antibody resistance |
title_full | An entropic safety catch controls hepatitis C virus entry and antibody resistance |
title_fullStr | An entropic safety catch controls hepatitis C virus entry and antibody resistance |
title_full_unstemmed | An entropic safety catch controls hepatitis C virus entry and antibody resistance |
title_short | An entropic safety catch controls hepatitis C virus entry and antibody resistance |
title_sort | entropic safety catch controls hepatitis c virus entry and antibody resistance |
topic | Microbiology and Infectious Disease |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333995/ https://www.ncbi.nlm.nih.gov/pubmed/35796426 http://dx.doi.org/10.7554/eLife.71854 |
work_keys_str_mv | AT stejskallenka anentropicsafetycatchcontrolshepatitiscvirusentryandantibodyresistance AT kalemeramphatsod anentropicsafetycatchcontrolshepatitiscvirusentryandantibodyresistance AT lewischarlotteb anentropicsafetycatchcontrolshepatitiscvirusentryandantibodyresistance AT palormachaela anentropicsafetycatchcontrolshepatitiscvirusentryandantibodyresistance AT walkerlucas anentropicsafetycatchcontrolshepatitiscvirusentryandantibodyresistance AT davitertina anentropicsafetycatchcontrolshepatitiscvirusentryandantibodyresistance AT leeswilliamd anentropicsafetycatchcontrolshepatitiscvirusentryandantibodyresistance AT mossdavids anentropicsafetycatchcontrolshepatitiscvirusentryandantibodyresistance AT kremydavlachoumyrto anentropicsafetycatchcontrolshepatitiscvirusentryandantibodyresistance AT kozlakidiszisis anentropicsafetycatchcontrolshepatitiscvirusentryandantibodyresistance AT gallogiulia anentropicsafetycatchcontrolshepatitiscvirusentryandantibodyresistance AT baileydalan anentropicsafetycatchcontrolshepatitiscvirusentryandantibodyresistance AT rosenbergwilliam anentropicsafetycatchcontrolshepatitiscvirusentryandantibodyresistance AT illingworthchristopherjr anentropicsafetycatchcontrolshepatitiscvirusentryandantibodyresistance AT shepherdadrianj anentropicsafetycatchcontrolshepatitiscvirusentryandantibodyresistance AT grovejoe anentropicsafetycatchcontrolshepatitiscvirusentryandantibodyresistance AT stejskallenka entropicsafetycatchcontrolshepatitiscvirusentryandantibodyresistance AT kalemeramphatsod entropicsafetycatchcontrolshepatitiscvirusentryandantibodyresistance AT lewischarlotteb entropicsafetycatchcontrolshepatitiscvirusentryandantibodyresistance AT palormachaela entropicsafetycatchcontrolshepatitiscvirusentryandantibodyresistance AT walkerlucas entropicsafetycatchcontrolshepatitiscvirusentryandantibodyresistance AT davitertina entropicsafetycatchcontrolshepatitiscvirusentryandantibodyresistance AT leeswilliamd entropicsafetycatchcontrolshepatitiscvirusentryandantibodyresistance AT mossdavids entropicsafetycatchcontrolshepatitiscvirusentryandantibodyresistance AT kremydavlachoumyrto entropicsafetycatchcontrolshepatitiscvirusentryandantibodyresistance AT kozlakidiszisis entropicsafetycatchcontrolshepatitiscvirusentryandantibodyresistance AT gallogiulia entropicsafetycatchcontrolshepatitiscvirusentryandantibodyresistance AT baileydalan entropicsafetycatchcontrolshepatitiscvirusentryandantibodyresistance AT rosenbergwilliam entropicsafetycatchcontrolshepatitiscvirusentryandantibodyresistance AT illingworthchristopherjr entropicsafetycatchcontrolshepatitiscvirusentryandantibodyresistance AT shepherdadrianj entropicsafetycatchcontrolshepatitiscvirusentryandantibodyresistance AT grovejoe entropicsafetycatchcontrolshepatitiscvirusentryandantibodyresistance |